Steady Growth Seen for Australian Renal Dialysis Machines Market

Consistency will define Australia’s renal dialysis machine market this decade.

GlobalData expects the sector to grow 5.5 percent between 2021 and 2030, driven by an increase in number of dialysis centers and rising end-stage renal disease cases. “Factors such as increase in the number of cases with end-stage renal disease (ESRD), majorly in the older age group, frequent need for performing dialysis and launch of new devices are strengthening the renal dialysis machines market,” said Uzma Takreem, a medical devices analyst at GlobalData. 
 
GlobalData’s report, “Renal Dialysis Machines (Nephrology and Urology Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact),” reveals that the Fresenius SE & Co KGaA, Baxter International Inc., and B. Braun Melsungen AG were the major players in Australia, accounting for about 70 percent of the market last year.
  
Hemodialysis machines accounted for more than 80 percent of the Australia’s renal dialysis machines market in 2021. More number of operational hemodialysis centers, physician expertise on the procedure, reimbursement provision, and availability of variety of devices are the factors accounting to the growth of hemodialysis machines market.
 
“Though hemodialysis is a mainstream treatment for patients with ESRD, growing demand for home-based care and needleless procedures during the pandemic, increasing awareness and low cost are expected to further increase the demand for peritoneal dialysis devices. Furthermore, the use of the new concept of precision medicine in the field of nephrology is also expected to create huge opportunities in the near future as it offers the advantage of preserving the residual kidney function,” Takreem said.